Report Illicit Drug Reactions- RIDR

PHE is piloting a new national system for reporting the effects of new psychoactive substances (NPS) and other drugs, in a similar way to how adverse effects of pharmaceutical drugs are reported to the MHRA’s Yellow Card Scheme.

The RIDR form enables professionals to report the effects of NPS that they encounter with patients. It is intended to be used by professionals who work in emergency departments, general practice, drug treatment services, sexual health services, mental health services and any other services where staff are coming into contact with people who have developed acute or chronic problems with NPS.

We are piloting this system in response to the need to understand more about the effects of new drugs, many of which are not well known and don’t have established methods for treating reactions and problems that develop from using them.

The pilot feeds into PHE’s wider work on developing a NPS information system. The overall aim of this system is to reduce the length of time between drug-related health harms emerging and developing effective treatment responses

As well as RIDR, PHE has set up a NPS clinical network to analyse data coming from RIDR and other existing drugs intelligence systems; to identify harms, patterns and agree appropriate clinical responses. The network brings together clinicians, other front-line experts and policy makers from across government.

RIDR is a joint project between PHE and the MHRA. This system uses the architecture of the Yellow Card Scheme, but is separately branded because of the different nature of what is being reported.

If you have any queries, please email